Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 117 | 2024 | 1178 | 22.980 |
Why?
|
Aminophenols | 24 | 2022 | 78 | 6.250 |
Why?
|
Quinolones | 21 | 2022 | 366 | 5.220 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 25 | 2023 | 437 | 4.390 |
Why?
|
Benzodioxoles | 13 | 2022 | 69 | 3.360 |
Why?
|
Aminopyridines | 6 | 2021 | 541 | 1.890 |
Why?
|
Self Care | 8 | 2017 | 786 | 1.800 |
Why?
|
Deoxyribonuclease I | 5 | 2022 | 228 | 1.650 |
Why?
|
Needs Assessment | 9 | 2021 | 1146 | 1.360 |
Why?
|
Cost of Illness | 7 | 2021 | 1852 | 1.150 |
Why?
|
Registries | 13 | 2021 | 8077 | 1.120 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 5 | 2024 | 687 | 1.120 |
Why?
|
Telemedicine | 6 | 2021 | 2853 | 1.080 |
Why?
|
Parents | 8 | 2019 | 3387 | 1.060 |
Why?
|
Forced Expiratory Volume | 12 | 2021 | 1741 | 1.050 |
Why?
|
Achilles Tendon | 2 | 2024 | 152 | 1.020 |
Why?
|
Respiratory Function Tests | 12 | 2021 | 1613 | 1.010 |
Why?
|
Thioglycolates | 1 | 2024 | 39 | 0.970 |
Why?
|
Polycyclic Compounds | 1 | 2024 | 32 | 0.960 |
Why?
|
Heel | 1 | 2024 | 36 | 0.960 |
Why?
|
Medication Therapy Management | 2 | 2018 | 127 | 0.920 |
Why?
|
Diterpenes | 1 | 2024 | 173 | 0.890 |
Why?
|
Health Services Accessibility | 8 | 2021 | 5133 | 0.860 |
Why?
|
Adolescent | 78 | 2022 | 85649 | 0.850 |
Why?
|
Models, Organizational | 4 | 2021 | 574 | 0.850 |
Why?
|
Continuity of Patient Care | 4 | 2021 | 1048 | 0.850 |
Why?
|
Spirometry | 2 | 2022 | 862 | 0.830 |
Why?
|
Communication Barriers | 2 | 2021 | 398 | 0.810 |
Why?
|
Patient Compliance | 5 | 2017 | 2680 | 0.810 |
Why?
|
Chronic Disease | 14 | 2022 | 9144 | 0.800 |
Why?
|
Lung | 17 | 2022 | 9826 | 0.780 |
Why?
|
Locomotion | 1 | 2023 | 378 | 0.750 |
Why?
|
Child | 62 | 2022 | 77478 | 0.740 |
Why?
|
Deductibles and Coinsurance | 1 | 2023 | 316 | 0.740 |
Why?
|
Young Adult | 60 | 2023 | 56350 | 0.730 |
Why?
|
Insurance Claim Review | 3 | 2018 | 720 | 0.700 |
Why?
|
Disease Transmission, Infectious | 2 | 2021 | 546 | 0.680 |
Why?
|
Quality of Life | 16 | 2022 | 12730 | 0.680 |
Why?
|
Equipment and Supplies | 1 | 2021 | 281 | 0.670 |
Why?
|
Sex Education | 1 | 2019 | 93 | 0.650 |
Why?
|
Running | 1 | 2023 | 478 | 0.640 |
Why?
|
Adaptation, Psychological | 4 | 2019 | 2575 | 0.620 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2017 | 16 | 0.620 |
Why?
|
Humans | 152 | 2024 | 742088 | 0.610 |
Why?
|
Pseudomonas Infections | 5 | 2014 | 608 | 0.610 |
Why?
|
Adult | 76 | 2024 | 213712 | 0.600 |
Why?
|
Women | 1 | 2018 | 230 | 0.570 |
Why?
|
Asthma | 9 | 2017 | 5955 | 0.550 |
Why?
|
Disease Progression | 11 | 2022 | 13256 | 0.550 |
Why?
|
Indoles | 6 | 2022 | 1834 | 0.550 |
Why?
|
Health Benefit Plans, Employee | 1 | 2018 | 332 | 0.540 |
Why?
|
Sweat | 4 | 2021 | 49 | 0.530 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 232 | 0.520 |
Why?
|
Home Care Services | 1 | 2021 | 602 | 0.520 |
Why?
|
Child Health Services | 1 | 2021 | 667 | 0.510 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 932 | 0.510 |
Why?
|
Tobramycin | 2 | 2012 | 69 | 0.510 |
Why?
|
Homozygote | 5 | 2022 | 1777 | 0.500 |
Why?
|
Eligibility Determination | 1 | 2018 | 403 | 0.500 |
Why?
|
Walking | 5 | 2024 | 1177 | 0.480 |
Why?
|
Ethics, Medical | 1 | 2019 | 791 | 0.480 |
Why?
|
Risk Adjustment | 1 | 2018 | 594 | 0.470 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1737 | 0.470 |
Why?
|
Reproductive Health Services | 3 | 2022 | 80 | 0.470 |
Why?
|
Health Status | 6 | 2021 | 4030 | 0.470 |
Why?
|
Treatment Refusal | 1 | 2017 | 416 | 0.460 |
Why?
|
Health Personnel | 4 | 2023 | 3210 | 0.460 |
Why?
|
Male | 90 | 2022 | 349538 | 0.450 |
Why?
|
Patient Participation | 2 | 2021 | 1445 | 0.450 |
Why?
|
Female | 93 | 2022 | 379592 | 0.450 |
Why?
|
Social Perception | 1 | 2017 | 424 | 0.450 |
Why?
|
Cough | 5 | 2021 | 555 | 0.440 |
Why?
|
Pseudomonas aeruginosa | 5 | 2019 | 1210 | 0.440 |
Why?
|
Quality Improvement | 5 | 2021 | 3738 | 0.440 |
Why?
|
Cost Savings | 1 | 2018 | 925 | 0.430 |
Why?
|
Physician's Role | 1 | 2019 | 942 | 0.420 |
Why?
|
Quality of Health Care | 5 | 2021 | 4369 | 0.420 |
Why?
|
Pneumonia | 1 | 2024 | 2117 | 0.410 |
Why?
|
Health Services | 3 | 2016 | 758 | 0.410 |
Why?
|
Drug Combinations | 5 | 2021 | 1961 | 0.410 |
Why?
|
Health Care Surveys | 2 | 2017 | 2451 | 0.400 |
Why?
|
Lung Diseases | 2 | 2021 | 1884 | 0.390 |
Why?
|
Resilience, Psychological | 1 | 2018 | 665 | 0.390 |
Why?
|
Teaching | 1 | 2019 | 1174 | 0.390 |
Why?
|
Self Concept | 1 | 2017 | 1025 | 0.380 |
Why?
|
Ambulatory Care | 2 | 2021 | 2706 | 0.370 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1636 | 0.370 |
Why?
|
Anti-Asthmatic Agents | 2 | 2017 | 533 | 0.370 |
Why?
|
United States | 30 | 2022 | 69693 | 0.370 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7153 | 0.360 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15530 | 0.360 |
Why?
|
Staphylococcal Infections | 2 | 2009 | 1398 | 0.350 |
Why?
|
Sexual Behavior | 7 | 2022 | 2050 | 0.330 |
Why?
|
Women's Health | 1 | 2018 | 2034 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2019 | 3915 | 0.310 |
Why?
|
Drug Costs | 2 | 2013 | 1104 | 0.310 |
Why?
|
Patient Advocacy | 1 | 2009 | 353 | 0.300 |
Why?
|
Sinusitis | 3 | 2021 | 922 | 0.300 |
Why?
|
Advance Directives | 1 | 2008 | 245 | 0.290 |
Why?
|
Health Expenditures | 2 | 2018 | 2346 | 0.280 |
Why?
|
Child, Preschool | 24 | 2021 | 40955 | 0.280 |
Why?
|
Mutation | 14 | 2023 | 29717 | 0.280 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2021 | 80 | 0.280 |
Why?
|
Time | 3 | 2021 | 530 | 0.270 |
Why?
|
Prescription Drugs | 1 | 2013 | 595 | 0.270 |
Why?
|
Adrenal Cortex Hormones | 2 | 2017 | 1847 | 0.270 |
Why?
|
Longitudinal Studies | 14 | 2021 | 13921 | 0.270 |
Why?
|
Administration, Inhalation | 4 | 2017 | 1104 | 0.260 |
Why?
|
Hypoglycemia | 2 | 2024 | 859 | 0.260 |
Why?
|
Hospitalization | 6 | 2019 | 10232 | 0.250 |
Why?
|
Pneumonia, Bacterial | 1 | 2008 | 316 | 0.250 |
Why?
|
Counseling | 2 | 2017 | 1521 | 0.250 |
Why?
|
Muscle Spindles | 1 | 2023 | 14 | 0.240 |
Why?
|
Hyperglycemia | 2 | 2024 | 1368 | 0.240 |
Why?
|
Motivation | 1 | 2014 | 1968 | 0.240 |
Why?
|
Health Services Needs and Demand | 4 | 2021 | 1411 | 0.240 |
Why?
|
Men's Health | 2 | 2022 | 73 | 0.240 |
Why?
|
Age Factors | 11 | 2021 | 18355 | 0.240 |
Why?
|
Employment | 1 | 2010 | 1124 | 0.230 |
Why?
|
Perception | 1 | 2010 | 1188 | 0.230 |
Why?
|
Costs and Cost Analysis | 3 | 2021 | 1679 | 0.230 |
Why?
|
Caregivers | 4 | 2023 | 2074 | 0.230 |
Why?
|
Tablets | 1 | 2024 | 147 | 0.230 |
Why?
|
Glucocorticoids | 1 | 2013 | 2107 | 0.230 |
Why?
|
Shoes | 1 | 2024 | 98 | 0.230 |
Why?
|
Rhinitis | 2 | 2021 | 691 | 0.210 |
Why?
|
Fatigue | 2 | 2021 | 1526 | 0.210 |
Why?
|
Steroids | 1 | 2008 | 931 | 0.210 |
Why?
|
Tendons | 2 | 2023 | 548 | 0.210 |
Why?
|
Swimming | 1 | 2023 | 206 | 0.210 |
Why?
|
Radius | 2 | 2016 | 422 | 0.210 |
Why?
|
Education, Medical | 1 | 2014 | 1717 | 0.210 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2275 | 0.200 |
Why?
|
Comparative Effectiveness Research | 2 | 2018 | 681 | 0.200 |
Why?
|
Muscle, Skeletal | 4 | 2024 | 4933 | 0.200 |
Why?
|
Respiratory Tract Infections | 3 | 2021 | 959 | 0.200 |
Why?
|
Recombinant Proteins | 3 | 2018 | 6608 | 0.200 |
Why?
|
Health Policy | 1 | 2014 | 2657 | 0.200 |
Why?
|
Muscles | 2 | 2023 | 1617 | 0.200 |
Why?
|
Social Support | 3 | 2019 | 2117 | 0.190 |
Why?
|
Advance Care Planning | 1 | 2008 | 660 | 0.190 |
Why?
|
Gait | 2 | 2023 | 784 | 0.190 |
Why?
|
Sickness Impact Profile | 2 | 2012 | 304 | 0.190 |
Why?
|
Bone Density | 3 | 2021 | 3469 | 0.180 |
Why?
|
Oximetry | 2 | 2021 | 467 | 0.180 |
Why?
|
Dyspnea | 1 | 2008 | 1298 | 0.180 |
Why?
|
Interviews as Topic | 3 | 2017 | 2536 | 0.180 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2024 | 436 | 0.180 |
Why?
|
Retrospective Studies | 17 | 2021 | 77098 | 0.180 |
Why?
|
Ankle Joint | 1 | 2023 | 411 | 0.170 |
Why?
|
Tibia | 2 | 2016 | 1075 | 0.170 |
Why?
|
Insurance, Health | 3 | 2023 | 2493 | 0.170 |
Why?
|
Pulmonary Medicine | 2 | 2019 | 213 | 0.170 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 24913 | 0.170 |
Why?
|
Insurance Coverage | 2 | 2023 | 1895 | 0.170 |
Why?
|
Treatment Outcome | 13 | 2021 | 62966 | 0.170 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1581 | 0.170 |
Why?
|
Fees, Pharmaceutical | 1 | 2018 | 64 | 0.170 |
Why?
|
Interdisciplinary Studies | 1 | 2019 | 89 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 375 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1110 | 0.160 |
Why?
|
Paranasal Sinuses | 2 | 2021 | 249 | 0.160 |
Why?
|
Organizational Innovation | 1 | 2021 | 559 | 0.160 |
Why?
|
Hospitals, Pediatric | 3 | 2021 | 1760 | 0.160 |
Why?
|
Crohn Disease | 2 | 2021 | 2301 | 0.160 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2030 | 0.160 |
Why?
|
Middle Aged | 23 | 2022 | 213127 | 0.160 |
Why?
|
Unemployment | 1 | 2019 | 214 | 0.160 |
Why?
|
Radiography, Thoracic | 2 | 2015 | 1265 | 0.160 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2021 | 501 | 0.150 |
Why?
|
Body Image | 1 | 2022 | 609 | 0.150 |
Why?
|
Pediatrics | 7 | 2021 | 3462 | 0.150 |
Why?
|
Anxiety | 4 | 2021 | 4279 | 0.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1183 | 0.150 |
Why?
|
Chlorides | 2 | 2021 | 667 | 0.150 |
Why?
|
Nutritional Status | 2 | 2015 | 1606 | 0.150 |
Why?
|
Drug Administration Schedule | 3 | 2016 | 4929 | 0.140 |
Why?
|
Health Surveys | 3 | 2019 | 4030 | 0.140 |
Why?
|
Cephalosporins | 1 | 2017 | 203 | 0.140 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2410 | 0.140 |
Why?
|
Emigration and Immigration | 1 | 2019 | 403 | 0.140 |
Why?
|
Ibuprofen | 1 | 2018 | 235 | 0.140 |
Why?
|
Pancreas | 2 | 2024 | 1684 | 0.140 |
Why?
|
Efficiency | 1 | 2019 | 462 | 0.140 |
Why?
|
Pharmacies | 1 | 2018 | 150 | 0.140 |
Why?
|
Sex Factors | 5 | 2021 | 10392 | 0.140 |
Why?
|
Communication | 3 | 2018 | 3728 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 670 | 0.130 |
Why?
|
Airway Resistance | 1 | 2017 | 404 | 0.130 |
Why?
|
Infant | 12 | 2024 | 35070 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1675 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2017 | 243 | 0.130 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2017 | 1208 | 0.130 |
Why?
|
Prescriptions | 1 | 2018 | 387 | 0.130 |
Why?
|
Logistic Models | 4 | 2015 | 13403 | 0.130 |
Why?
|
Medication Adherence | 2 | 2018 | 2055 | 0.130 |
Why?
|
Health Status Indicators | 1 | 2021 | 968 | 0.130 |
Why?
|
Cohort Studies | 8 | 2021 | 40450 | 0.130 |
Why?
|
Medical History Taking | 1 | 2019 | 783 | 0.130 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1331 | 0.130 |
Why?
|
Public Policy | 1 | 2019 | 572 | 0.130 |
Why?
|
Sampling Studies | 2 | 2014 | 623 | 0.130 |
Why?
|
Eating | 1 | 2022 | 1535 | 0.130 |
Why?
|
Contraception | 1 | 2018 | 356 | 0.130 |
Why?
|
Ergocalciferols | 1 | 2015 | 110 | 0.120 |
Why?
|
Nebulizers and Vaporizers | 1 | 2015 | 139 | 0.120 |
Why?
|
Terminal Care | 2 | 2017 | 1688 | 0.120 |
Why?
|
Knee Joint | 1 | 2023 | 1679 | 0.120 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 430 | 0.120 |
Why?
|
Directive Counseling | 1 | 2015 | 166 | 0.120 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6483 | 0.120 |
Why?
|
Adolescent Medicine | 1 | 2014 | 72 | 0.120 |
Why?
|
Fertility | 1 | 2018 | 770 | 0.110 |
Why?
|
Databases, Factual | 2 | 2019 | 7716 | 0.110 |
Why?
|
Adolescent Health Services | 1 | 2015 | 215 | 0.110 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2414 | 0.110 |
Why?
|
Forecasting | 2 | 2014 | 2948 | 0.110 |
Why?
|
Physician-Patient Relations | 3 | 2011 | 3215 | 0.110 |
Why?
|
Time Factors | 4 | 2021 | 40054 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2022 | 5062 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1314 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2017 | 663 | 0.110 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7901 | 0.110 |
Why?
|
Propensity Score | 2 | 2018 | 1771 | 0.110 |
Why?
|
Body Composition | 1 | 2022 | 2400 | 0.110 |
Why?
|
Survivors | 2 | 2016 | 2286 | 0.100 |
Why?
|
Health Education | 1 | 2019 | 1053 | 0.100 |
Why?
|
Elasticity Imaging Techniques | 1 | 2017 | 388 | 0.100 |
Why?
|
Otolaryngology | 1 | 2019 | 644 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39004 | 0.100 |
Why?
|
Medically Uninsured | 1 | 2018 | 852 | 0.100 |
Why?
|
Program Evaluation | 2 | 2018 | 2485 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5304 | 0.100 |
Why?
|
Genotype | 3 | 2021 | 12946 | 0.100 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3391 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12242 | 0.100 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 975 | 0.100 |
Why?
|
Vocational Guidance | 1 | 2010 | 13 | 0.100 |
Why?
|
Palliative Care | 2 | 2017 | 3478 | 0.100 |
Why?
|
Nut Hypersensitivity | 1 | 2010 | 23 | 0.100 |
Why?
|
Endoscopy | 1 | 2021 | 1774 | 0.100 |
Why?
|
Reproducibility of Results | 5 | 2022 | 19862 | 0.100 |
Why?
|
Drug Resistance | 1 | 2017 | 1608 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 921 | 0.090 |
Why?
|
Egg Hypersensitivity | 1 | 2010 | 44 | 0.090 |
Why?
|
Depression | 3 | 2020 | 7733 | 0.090 |
Why?
|
Ventilator Weaning | 1 | 2011 | 148 | 0.090 |
Why?
|
Self Report | 3 | 2019 | 3548 | 0.090 |
Why?
|
Respiratory Sounds | 2 | 2014 | 693 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 537 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2022 | 3187 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2575 | 0.090 |
Why?
|
Patients | 2 | 2014 | 892 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2022 | 3278 | 0.090 |
Why?
|
Qualitative Research | 1 | 2018 | 2680 | 0.090 |
Why?
|
Confidentiality | 1 | 2014 | 609 | 0.090 |
Why?
|
Foundations | 2 | 2020 | 94 | 0.090 |
Why?
|
Inhalation | 1 | 2010 | 143 | 0.090 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 824 | 0.090 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2016 | 770 | 0.090 |
Why?
|
Professional Practice | 1 | 2011 | 326 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3336 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5948 | 0.080 |
Why?
|
Boston | 4 | 2015 | 9305 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1574 | 0.080 |
Why?
|
Weight Gain | 1 | 2019 | 2282 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2017 | 1155 | 0.080 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 363 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1901 | 0.080 |
Why?
|
Blood Glucose | 4 | 2024 | 6249 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2276 | 0.080 |
Why?
|
Respiratory Therapy | 1 | 2008 | 132 | 0.080 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2011 | 306 | 0.080 |
Why?
|
Ion Channel Gating | 2 | 2021 | 437 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3839 | 0.080 |
Why?
|
Transportation | 1 | 2009 | 211 | 0.080 |
Why?
|
Absorptiometry, Photon | 3 | 2022 | 1726 | 0.080 |
Why?
|
Body Mass Index | 4 | 2022 | 12695 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2022 | 12017 | 0.070 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2007 | 88 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 112 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3014 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4214 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2022 | 21719 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1864 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1794 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1436 | 0.070 |
Why?
|
Exercise | 2 | 2022 | 5611 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1009 | 0.070 |
Why?
|
Vital Capacity | 2 | 2021 | 922 | 0.070 |
Why?
|
Family Relations | 1 | 2008 | 321 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2102 | 0.070 |
Why?
|
Self Efficacy | 1 | 2009 | 610 | 0.070 |
Why?
|
Massachusetts | 4 | 2014 | 8662 | 0.070 |
Why?
|
Mental Health | 1 | 2019 | 2997 | 0.070 |
Why?
|
Survival Analysis | 3 | 2018 | 10248 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5724 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10943 | 0.060 |
Why?
|
Affective Symptoms | 1 | 2008 | 407 | 0.060 |
Why?
|
Prospective Studies | 7 | 2024 | 53187 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2051 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2011 | 782 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4664 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1209 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3869 | 0.060 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1144 | 0.060 |
Why?
|
Pregnancy Rate | 2 | 2017 | 643 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2615 | 0.060 |
Why?
|
Bionics | 1 | 2024 | 42 | 0.060 |
Why?
|
Medicaid | 1 | 2017 | 2716 | 0.060 |
Why?
|
Necrosis | 1 | 2008 | 1643 | 0.060 |
Why?
|
Physicians | 4 | 2017 | 4554 | 0.060 |
Why?
|
Prevalence | 4 | 2021 | 15194 | 0.060 |
Why?
|
Risk Factors | 5 | 2018 | 72145 | 0.060 |
Why?
|
Biofeedback, Psychology | 1 | 2023 | 115 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2018 | 25575 | 0.050 |
Why?
|
Data Collection | 2 | 2011 | 3339 | 0.050 |
Why?
|
Insulin Infusion Systems | 1 | 2024 | 212 | 0.050 |
Why?
|
Mechanical Phenomena | 1 | 2023 | 140 | 0.050 |
Why?
|
Saline Solution, Hypertonic | 1 | 2022 | 110 | 0.050 |
Why?
|
Drug Monitoring | 2 | 2019 | 956 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 1945 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1140 | 0.050 |
Why?
|
Knee | 1 | 2023 | 274 | 0.050 |
Why?
|
Cardiology | 1 | 2012 | 1658 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8328 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2022 | 150 | 0.050 |
Why?
|
Aged | 8 | 2021 | 162944 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2021 | 135 | 0.050 |
Why?
|
Schools | 1 | 2009 | 1425 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2566 | 0.050 |
Why?
|
Family | 2 | 2011 | 3144 | 0.050 |
Why?
|
Regression Analysis | 1 | 2009 | 6452 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3306 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16331 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6365 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 5979 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2021 | 342 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2019 | 153 | 0.040 |
Why?
|
Posture | 1 | 2023 | 958 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23320 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4551 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 546 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1100 | 0.040 |
Why?
|
Biological Availability | 1 | 2019 | 396 | 0.040 |
Why?
|
Otitis Media | 1 | 2021 | 277 | 0.040 |
Why?
|
Transaminases | 1 | 2019 | 199 | 0.040 |
Why?
|
Israel | 1 | 2021 | 795 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4681 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12344 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11695 | 0.040 |
Why?
|
Vomiting | 1 | 2021 | 632 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1167 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 528 | 0.040 |
Why?
|
Diet Surveys | 1 | 2022 | 1172 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 281 | 0.040 |
Why?
|
Mental Disorders | 1 | 2017 | 6587 | 0.040 |
Why?
|
Germany | 1 | 2019 | 860 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5385 | 0.040 |
Why?
|
North America | 1 | 2021 | 1249 | 0.040 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2017 | 74 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20086 | 0.040 |
Why?
|
Sodium Chloride | 1 | 2019 | 625 | 0.040 |
Why?
|
Health Care Costs | 1 | 2010 | 3203 | 0.040 |
Why?
|
Half-Life | 1 | 2017 | 658 | 0.040 |
Why?
|
Family Health | 1 | 2021 | 1282 | 0.040 |
Why?
|
Movement | 1 | 2023 | 1470 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1792 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2012 | 4566 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 341 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1839 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1151 | 0.030 |
Why?
|
Audiometry | 1 | 2016 | 242 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 390 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12705 | 0.030 |
Why?
|
New England | 1 | 2017 | 1021 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15056 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12773 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1767 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7770 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 977 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 311 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 306 | 0.030 |
Why?
|
Hemoptysis | 1 | 2014 | 155 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1612 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 29087 | 0.030 |
Why?
|
Immunophenotyping | 1 | 1997 | 1866 | 0.030 |
Why?
|
Sputum | 1 | 2014 | 474 | 0.030 |
Why?
|
Psychometrics | 2 | 2012 | 2999 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1661 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 1871 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2556 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 2866 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1997 | 1423 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 1970 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2900 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3211 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7645 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3266 | 0.020 |
Why?
|
Esophageal pH Monitoring | 1 | 2011 | 190 | 0.020 |
Why?
|
Vital Signs | 1 | 2011 | 141 | 0.020 |
Why?
|
Prognosis | 3 | 2019 | 29010 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1589 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2818 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10372 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1837 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14720 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3528 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6575 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1449 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2133 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2012 | 3527 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2017 | 1246 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2014 | 1460 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6534 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2010 | 392 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3913 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21596 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2552 | 0.020 |
Why?
|
Vitamins | 1 | 2015 | 1608 | 0.020 |
Why?
|
Proton Pump Inhibitors | 1 | 2011 | 521 | 0.020 |
Why?
|
Community Health Centers | 1 | 2010 | 428 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3937 | 0.020 |
Why?
|
Aging | 1 | 2023 | 8626 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8297 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2450 | 0.010 |
Why?
|
Poverty | 1 | 2015 | 2646 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2604 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2011 | 1199 | 0.010 |
Why?
|
Cytokines | 1 | 1997 | 7317 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9846 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3766 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4554 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3589 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5238 | 0.010 |
Why?
|
Patient Care Team | 1 | 2011 | 2527 | 0.010 |
Why?
|
Premature Birth | 1 | 2011 | 1713 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2013 | 0.010 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1997 | 16 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1997 | 43 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2658 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10578 | 0.010 |
Why?
|
Clone Cells | 1 | 1997 | 1692 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12958 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15994 | 0.000 |
Why?
|